Vertex Pharmaceuticals Inc
XBER:VX1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vertex Pharmaceuticals Inc
XBER:VX1
|
US |
|
H
|
HeidelbergCement AG
F:HEI
|
DE |
|
S
|
Shoprite Holdings Ltd
JSE:SHP
|
ZA |
|
Ciena Corp
NYSE:CIEN
|
US |
|
S
|
Sumitomo Mitsui Financial Group Inc
DUS:XMF
|
JP |
|
W
|
Willis Towers Watson PLC
SWB:WTY
|
UK |
|
Amazon.com Inc
NASDAQ:AMZN
|
US |
|
C
|
Capital One Financial Corp
XBER:CFX
|
US |
|
Amgen Inc
NASDAQ:AMGN
|
US |
|
A
|
Advanced Energy Industries Inc
XBER:AVX
|
US |
|
Tower Bersama Infrastructure Tbk PT
F:6TB
|
ID |
|
Ford Motor Co
NYSE:F
|
US |
|
H
|
Hikari Tsushin Inc
OTC:HKTGF
|
JP |
|
MGP Ingredients Inc
NASDAQ:MGPI
|
US |
|
NOW Inc
NYSE:DNOW
|
US |
|
Komercni Banka as
PSE:KOMB
|
CZ |
Wall St Price Targets
VX1 Price Targets Summary
Vertex Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for VX1 is 463.66 EUR with a low forecast of 275.54 EUR and a high forecast of 556.4 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VX1's stock price target?
Price Target
463.66
EUR
According to Wall Street analysts, the average 1-year price target for VX1 is 463.66 EUR with a low forecast of 275.54 EUR and a high forecast of 556.4 EUR.
What is the Revenue forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 3 years is 10%.
What is the Gross Profit forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 3 years is 11%.
What is the Operating Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Operating Income has been 42%. The projected CAGR for the next 3 years is 17%.
What is the Pre-Tax Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 47%. The projected CAGR for the next 3 years is 20%.
What is the Net Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
18%
The compound annual growth rate for Net Income over the next 3 years is 18%.
